Abstract
Nanoparticles have been considered for a while as unlikely to penetrate healthy (undisrupted) skin [1]. It is universally accepted now that their size is an important factor which determines their absorption into the skin. In 2008 a European forum, the Scientific Committee on Consumer Products, made public their opinion about interactions between nanostructures and the skin. Their statements were made based on the sizes involved [2] and showed that only for particles smaller than 10 nm there is evidence of penetration as far as the dermis. For particles of 20 nm or larger there is no evidence of penetration into viable (undisrupted) skin layers. The conclusion summarizes experiments done on both human and porcine skin. The same document states that the situation is different for hair follicles which allow deep penetration of particles 20 nm or larger and can function as reservoirs for nanoparticles. Mechanical effects on the skin (e.g. wrinkles, flexing) affect (modulate) penetration as well.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nohynek GJ, Lademann J, Ribaud C, Roberts MS (2007) Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 37:251–277
European Commission (2008) On regulatory aspects of nanomaterials. In: Scientific Committee on Consumer Products Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee. Regulatory Aspects of Nanomaterials [SEC(2008) 2036] Commission of the European Communities, Brussels, 17.6.2008 COM(2008) 366 final.
Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, Lopez-Quintela MA (2007) Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 127:1701–1712
Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EMT, Yoong C, Robertson TA, Soyer HP, Roberts MS (2011) Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63:470–491
Draelos ZD (2013) Enhancement of topical delivery with nanocarriers. In: Nasir A, Friedman A, Wang S (eds) Nanotechnology in dermatology. Springer, New York/Heidelberg/Dordrecht/London, pp 87–93
Chen DL, Zheng D, Paller AS (2013) Nano-based gene therapy for dermatologic diseases. In: Nasir A, Friedman A, Wang S (eds) Nanotechnology in dermatology. Springer, New York/Heidelberg/Dordrecht/London, pp 109–117
Baroli B (2010) Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci 99(1):21–51
Kuehn BM (2007) Chronic wound guidelines issued. JAMA 297(9):938–939
Murphy RJ, Pristinski D, Migler K, Douglas JF, Prabhu VM (2010) Dynamic light scattering investigations of nanoparticles aggregation following a light-induced pH jump. J Chem Phys 132(19):194903–194906
Kuntsche J, Bunjes H, Fahr A, Pappinen S, Ronkko S, Suhonen M, Urtti A (2008) Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model. Int J Pharm 354:180–195
Leonida MD, Banjade S, Vo T, Anderle G, Haas GJ, Philips N (2011) Nanocomposite materials with antimicrobial activity based on chitosan. Int J Nano Biomater 3(4):316–333
Ma Y, Zhou T, Zhao C (2008) Preparation of chitosan-nylon-6 blended membranes containing silver ions as antibacterial materials. Carbohydr Res 343(2):230–237
Albasarah YY, Somavarapu S, Stapleton P, Taylor KMG (2010) Chitosan-coated antifungal formulations for nebulization. J Pharm Pharmacol 62(7):821–828
Chen H, Chang X, Du D (2006) Podophyllotoxin-loaded solid-lipid nanoparticles for epidermal targeting. J Control Release 110(2):296–306
Dianzani C, Zara GP, Maina G, Pettazzoni P, Pizzimenti S, Rossi F, Gigliotti CL, Ciamporcero ES, Daga M, Barrera G (2014) Drug delivery nanoparticles in skin cancers. Biomed Res Int. doi:10.1155/2014/895986, ID 895986, 13 pp
Friedman A, Blecher K (2013) Nanotechnology in the treatment of infectious diseases. In: Nasir A, Friedman A, Wang S (eds) Nanotechnology in dermatology. Springer, New York/Heidelberg/Dordrecht/London, pp 187–200
Makidon PE, Bielinska AU, Nigavekar SS (2008) Preclinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One 3(8):e2954
Muttil P, Prego C, Garcia-Contreras L (2010) Immunization of Guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary route. AAPS J 14(2):330–337
Moussaoui N, Cansell M, Denizot A (2002) Marinosomes, marine lipid-based liposomes, physical characterization and potential application in cosmetics. Int J Pharm 242:361–365
“Liposome”. Licensed under Public Domain. https://en.wikipedia.org/wiki/File:Liposome.jpg#/media/File:Liposome.jpg. Accessed 17 Sept 2015
Slingerland M, Guchelaar H, Gelderblom H (2012) Liposomal drug formulations in cancer therapy: 15 years along the road. Drug Discov Today 17(3–4):160–166
Muthu MS, Feng S (2013) Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success. Expert Opin Drug Deliv 10(2):151–155
Huang S (2008) Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev 60(10):1167–1176
Witting M, Obst K, Friess W, Hedtrich S (2015) Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers. Biotechnol Adv. http://dx.doi.org/10/1016/biotechadv.2015.01.010. Accessed 17 Sept 2015
Torchilin VP (2007) Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 24(1):1–16
Zhang L, Gu FX, Chan JM, Wang Z, Langer RS, Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83(5):761–769
Zhang L, Radovic-Moreno AF, Alexis F (2007) Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem 2(9):1268–1271
Kaur IP, Meenakshi K, Agrawal R (2007) Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageing. Ageing Res Rev 6(4):271–288
Mehnert W, Mäder K (2001) Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev 47(2–3):165–196
Mosallaei N, Jaafari MR, Hanafi-Bojd MY, Golmohammadzadeh S, Malaekeh-Nikouei B (2013) Decetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro and in vivo evaluations. J Pharm Sci 102(6):1994–2004
“Graphs” by original uploader Olukin at en.wikipedia Licensed under Public Domain via Wikimedia Commons. https://commons.wikimedia.org/wiki/File:Graphs.jpg#/media/File:Graphs.jpg. Accessed 17 Sept 2015
Jaracz S, Chen J, Kuznetsova LV, Ojima I (2005) Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 13(17):5043–5054
Larocque J, Bharali J, Mousa SA (2009) Cancer detection and treatment: the role of nanomedicines. Mol Biotechnol 42(3):358–366
Singh R, Lillard JW (2009) Nanoparticle-based drug delivery. Exp Mol Pathol 86(3):215–223
Chen J, Shao R, Zhang XD, Chen C (2013) Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. Int J Nanomed 8(1):2677–2688
Battah S, Balaratnam S, Casas A, O’Neill S, Edwards C, Battle A, Dobbin P, McRobert AJ (2007) Macromolecular delivery of 5-aminolevulinic acid for photodynamic therapy using dendrimer conjugates. Mol Cancer Ther 6(3):876–885
Chen W, Meng F, Cheng R, Zhong Z (2010) pH-sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J Control Release 142:40–46
Zhao Y, Brown MB, Jones SA (2010) Pharmaceutical foams: are they the answer to the dilemma of topical nanoparticles? Nanomed Nanotechnol Biol Med 6:227–236
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Leonida, M.D., Kumar, I. (2016). Nanoparticles, Nanomaterials and Nanocarriers. In: Bionanomaterials for Skin Regeneration. SpringerBriefs in Bioengineering. Springer, Cham. https://doi.org/10.1007/978-3-319-39168-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-39168-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39166-3
Online ISBN: 978-3-319-39168-7
eBook Packages: EngineeringEngineering (R0)